HAVENS ADVISORS LLC - Q3 2020 holdings

$108 Million is the total value of HAVENS ADVISORS LLC's 27 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 104.8% .

 Value Shares↓ Weighting
WLTW BuyWILLIS TOWERS WATSON PLC LTD$10,650,000
+51.7%
51,000
+43.1%
9.86%
-5.9%
WMGI BuyWRIGHT MED GROUP NV$10,384,000
+7.5%
340,000
+4.6%
9.61%
-33.3%
IMMU NewIMMUNOMEDICS INC$8,163,00096,000
+100.0%
7.56%
MXIM NewMAXIM INTEGRATED PRODS INC$7,978,000118,000
+100.0%
7.38%
ACIA NewACACIA COMMUNICATIONS INC$6,733,00099,900
+100.0%
6.23%
VAR NewVARIAN MED SYS INC$6,708,00039,000
+100.0%
6.21%
ADSW BuyADVANCED DISP SVCS INC DEL$5,744,000
+81.3%
190,000
+81.0%
5.32%
+12.4%
TIF SellTIFFANY & CO NEW$5,677,000
-24.3%
49,000
-20.3%
5.26%
-53.1%
MNTA NewMOMENTA PHARMACEUTICALS INC$5,615,000107,000
+100.0%
5.20%
BREW BuyCRAFT BREW ALLIANCE INC$5,456,000
+108.6%
330,648
+94.5%
5.05%
+29.3%
GRUB NewGRUBHUB INC$5,044,00069,738
+100.0%
4.67%
HUD NewHUDSON LTD$4,949,000651,170
+100.0%
4.58%
NAV BuyNAVISTAR INTL CORP NEW$4,789,000
+263.6%
110,000
+135.5%
4.43%
+125.5%
LVGO NewLIVONGO HEALTH INC$3,602,00025,718
+100.0%
3.33%
FIT BuyFITBIT INCcl a$2,568,000
+95.7%
369,000
+81.7%
2.38%
+21.3%
SG NewSIRIUS INTERNATIONAL INSURAN$1,988,000171,936
+100.0%
1.84%
VRTU NewVIRTUSA CORP$1,819,00037,000
+100.0%
1.68%
SOGO NewSOGOU INCadr repstg a$1,671,000188,000
+100.0%
1.55%
GNW NewGENWORTH FINL INC$1,548,000462,000
+100.0%
1.43%
ETFC BuyE TRADE FINANCIAL CORP$1,236,000
+59.1%
24,689
+58.0%
1.14%
-1.4%
BMYRT BuyBRISTOL-MEYERS SQUIBB COright 99/99/9999$1,062,000
-12.7%
472,000
+38.8%
0.98%
-45.9%
WCC  WESCO INTL INC$1,020,000
+5.6%
36,4190.0%0.94%
-34.5%
TCO SellTAUBMAN CTRS INC$999,000
-54.6%
30,000
-48.5%
0.92%
-71.9%
AIMT NewAIMMUNE THERAPEUTICS INC$861,00024,993
+100.0%
0.80%
DLPH SellDELPHI TECHNOLOGIES PLC$852,000
-26.0%
51,000
-37.0%
0.79%
-54.1%
PACB SellPACIFIC BIOSCIENCES CALIF INC$553,000
-45.8%
56,000
-81.1%
0.51%
-66.4%
GNW NewGENWORTH FINL INCput$358,000107,000
+100.0%
0.33%
TERP ExitTERRAFORM PWR INC$0-12,041
-100.0%
-0.33%
PTLA ExitPORTOLA PHARMACEUTICALS INC$0-36,500
-100.0%
-0.98%
FSCT ExitFORESCOUT TECHNOLOGIES INC$0-43,198
-100.0%
-1.37%
ExitCAESARS ENTMT CORPnote 5.000%10/0$0-927,234
-100.0%
-2.34%
WUBA Exit58 COM INCspon adr rep a$0-96,500
-100.0%
-7.77%
EE ExitEL PASO ELEC CO$0-84,000
-100.0%
-8.40%
CZR ExitCAESARS ENTMT CORP$0-486,489
-100.0%
-8.81%
LM ExitLEGG MASON INC$0-140,000
-100.0%
-10.40%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-10-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMGEN INC18Q3 20171.5%
LIFEPOINT HOSPITALS INC18Q3 20170.2%
YAHOO INC14Q3 20161.2%
WESTERN UN CO10Q3 20152.6%
JUNIPER NETWORKS INC10Q3 20152.1%
NXP SEMICONDUCTORS NV9Q4 201811.9%
TIME WARNER CABLE INC9Q1 20167.9%
TRIBUNE MEDIA CO9Q2 201910.0%
HUDSON CITY BANCORP9Q3 20157.6%
WILLIS TOWERS WATSON PLC LTD8Q1 202210.5%

View HAVENS ADVISORS LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-01-25
13F-HR2022-10-12
13F-HR2022-08-15
13F-HR2022-04-13
13F-HR2022-01-31
13F-HR2021-10-07
13F-HR2021-07-14
13F-HR2021-04-14
13F-HR2021-02-02
13F-HR2020-10-08

View HAVENS ADVISORS LLC's complete filings history.

Compare quarters

Export HAVENS ADVISORS LLC's holdings